Symbicort Single Inhaler Treatment Proven for Better Asthma Prevention and Management

Published: 2005-01-20 06:56:00

Updated: 2005-01-20 06:56:00

Clinical results from a major asthma study known as the STAY trial indicate that a novel asthma treatment approach using a single inhaler concept is more effective for prevention and management of asthma attacks for patients of all ages.

According to AstraZeneca, the single inhaler treatment u...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK